Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBITDA: 2016-2021

Historic EBITDA for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' EBITDA fell 36.25% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$10.8 million for FY2024, which is 2.82% down from last year.
  • Per ENDRA Life Sciences' latest filing, its EBITDA stood at -$3.1 million for Q4 2021, which was down 15.88% from -$2.7 million recorded in Q3 2021.
  • Over the past 5 years, ENDRA Life Sciences' EBITDA peaked at -$360,697 during Q1 2017, and registered a low of -$3.3 million during Q3 2020.
  • Moreover, its 3-year median value for EBITDA was -$2.8 million (2019), whereas its average is -$2.8 million.
  • As far as peak fluctuations go, ENDRA Life Sciences' EBITDA crashed by 686.70% in 2018, and later climbed by 27.99% in 2020.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' EBITDA stood at -$2.3 million in 2017, then grew by 12.79% to -$2.0 million in 2018, then tumbled by 56.31% to -$3.1 million in 2019, then climbed by 27.99% to -$2.3 million in 2020, then crashed by 36.25% to -$3.1 million in 2021.
  • Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.